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Abstract.  Extracellular matrix  (ECM) plays an impor- 
tant role in the maintenance  of mammary epithelial 
differentiation in culture.  We asked whether changes in 
mouse mammary specific function in vivo correlate 
with changes in the ECM.  We showed, using expres- 
sion of E-casein as a marker,  that the temporal expres- 
sion of ECM-degrading  proteinases and their inhibi- 
tors during  lactation and involution are inversely 
related to functional differentiation.  After a lactation 
period of 9 d, mammary epithelial  cells maintained 
/~-casein expression up to 5 d of involution. Two metal- 
loproteinases,  72-kD gelatinase (and its 62-kD active 
form), and stromelysin, and a  serine proteinase tissue 
plasminogen activator were detected by day four of in- 
volution,  and maintained  expression until at least day 
10.  The expression of their inhibitors,  the tissue inhib- 
itor of metalloproteinases (TIMP) and plasminogen ac- 
tivator inhibitor-I,  preceded the onset of ECM- 
degrading proteinase expression and was detected by 
day two of involution,  and showed a  sharp peak of 
expression centered on days 4-6 of involution.  When 
involution was accelerated by decreasing lactation to 
2 d, there was an accelerated loss of/~-casein expres- 
sion evident by day four and a  shift in expression of 
ECM-remodeling proteinases and inhibitors  to a  focus 
at 2-4 d of involution.  To further extend the correla- 
tion between mammary-specific function and ECM 
remodeling  we initiated  involution by sealing just one 
gland in an otherwise hormonally  sufficient lactating 
animal.  Alveoli in the sealed gland contained casein 
for at least 7 d after sealing,  and closely resembled 
those in a lactating gland.  The relative expression of 
TIMP in the sealed gland increased,  whereas the ex- 
pression of stromelysin was much lower than that of a 
hormone-depleted involuting gland,  indicating  that the 
higher the ratio of TIMP to ECM-degrading pro- 
teinases the slower the process of involution.  To test 
directly the functional role of ECM-degrading  pro- 
teinases in the loss of tissue-specific function we 
artificially perturbed the ECM-degrading proteinase- 
inhibitor ratio in a normally involuting gland by main- 
taining high concentrations of TIMP protein with the 
use of surgically implanted slow-release pellets.  In a 
concentration-dependent  fashion,  involuting mammary 
glands that received TIMP implants maintained high 
levels of casein and delayed alveolar regression.  These 
data suggest that the balance of ECM-degrading pro- 
teinases and their inhibitors  regulates the organization 
of the basement membrane and the tissue-specific 
function of the mammary gland.  During involution an 
excess of active ECM-degrading proteinases and/or an 
absence of inhibitors disrupts cell-ECM interaction, 
leading to loss of differentiated lactational  phenotype. 
XTENSIVE studies  in  culture  have  shown  that  the 
interaction  of a  cell  with  its  extracellular  matrix 
(ECM) t has a profound influence  on the functional 
status of epithelia  (reviewed by Talhouk et al.,  1991a; Watt, 
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1991; Stoker et al., 1990). Evidence in support of an active 
role for ECM in vivo (Wicha et al., 1980) in the development 
and function of tissues is beginning  to unfold (Darribe're et 
al., 1990; Silberstein et al., 1990). One way in which the cell 
regulates its interaction  with ECM is through remodeling  of 
its microenvironment  by secretion of ECM-degrading pro- 
teinases  and  inhibitors  (Matrisian,  1990;  Alexander  and 
Werb,  1991). ECM-degrading proteinases were previously 
shown to correlate with metastases and tumor growth pre- 
sumably by facilitating  invasion of cells through their base- 
ment membrane (Goldberg and Eisen, 1991). However, they 
are also believed to be involved in regulating  development 
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1991b; Wilson et al., 1991; Brenner et al., 1989; Fukuda et 
al.,  1988;  Beers et al.,  1975). 
To  explore  further  the  role  that  ECM-degrading  pro- 
teinases and their inhibitors play in regulating normal tissue 
development and tissue-specific function, we have used the 
mouse mammary gland as a model for our studies. We previ- 
ously demonstrated that basement membrane remodeling 
activity in vivo is lowest during lactation, when the mam- 
mary gland is fully differentiated, and highest during involu- 
tion when the gland ceases to produce milk (Talhouk et al., 
1991b). Previous studies have shown that mammary epithe- 
lial cells can acquire function in culture only when they are 
provided with an exogenous basement membrane or when 
they deposit their own basement membrane (Streuli and Bis- 
sell,  1990;  Li et al.,  1987;  Blum et al.,  1987).  That the 
differentiation  acquired  in  culture  is  a  result  of  direct 
ceU-ECM interaction has been shown by disruption of func- 
tion with the use of blocking antibodies against integrins 
(Streuli et al.,  1991). 
We now have asked whether the loss of  mammary function 
during involution is due to ECM-remodeling events as initi- 
ated by ECM-degrading proteinases. We demonstrate that 
the loss of  differentiated function of  the mammary gland dur- 
ing involution is directly correlated with events that modu- 
late celI-ECM interaction. Further, we provide evidence that 
despite hormonal modulation, involution can be delayed if 
the degradation of the basement membrane is inhibited after 
cessation of milking. The data presented here support the hy- 
pothesis  that a  critical  and  coordinated balance  between 
ECM-degrading proteinases and their inhibitors regulates 
tissue development and function in vivo. 
Materials and Methods 
Mammary Tissue 
Mammary tissue obtained from primigravidae female CD-1 mice (Charles 
River, Wilmington, MA) were used in all experiments. Tissue was collected 
from mice at various stages of lactation and during involution of the gland. 
The intervals of lactation or involution for tissue collections are indicated 
in the respective experiments.  Tissue samples from at least two mice were 
collected at each stage of development.  Each experiment was repeated twice 
except for cauterization experiments.  All experiments were performed un- 
der protocols approved by the Animal Welfare  and Research  Committee, 
Lawrence Berkeley  Laboratory (Berkeley, CA). 
RNA Preparation and RNA Blot Analysis 
Total RNA was prepared from mammary tissue according to the procedure 
of Chomczynski and Sacchi (1987).  RNA samples  were  resolved  on 1% 
agarose formaldehyde gels under denaturing conditions,  and transferred to 
nylon membranes (Hybond-N; Amersbam Corp., Arlington Heights,  IL). 
The RNA was hybridized to mouse eDNA probes radiolabeled with 32p. 
dCTP by random priming (Feinberg and Vogelstein,  1984). FOr E-casein 
(pBCL-1, subclone derived from a plasmid provided by J. Rosen,  Baylor 
College of Medicine, Bayior, TX) blots with 2/~g total RNA were used. 
Blots with 20 #g total RNA were used for stromelysin (SL) (Ostrowski et 
al.,  1988), full-length probe provided by L. Matrisian (Vanderbilt Univer- 
sity, Nashville,  TN),  tissue plasminogen activator (tPA) (RicHes et ai., 
1988), probe provided by R. RicHes (State University of New York, Stony 
Brook, NY), tissue inhibitor of metalloproteinases (TIMP) (Gewert et al., 
1987), probe provided by B. Coulombe (Universite de Montreal, Canada), 
and plasminogen activator inhibitor-1 (PAI-1)  (Prendergast and Cole, 1989), 
probe provided by M.  Cole (Princeton University,  Princeton, NJ).  Pre- 
hybridization, hybridization, and post-hybridization washes  were carried 
out according to Streuli  and Bissell  (1990).  The blots were exposed  to 
XAR-5  film  (Eastman Kodak  Co.,  Rochester,  NY)  for fluorography  at 
-80~  Positions for RNA size standards (2 #g per lane, from Life Tech- 
nologies Inc., Gaithersburg, MD) were determined after transfer by staining 
the marker lane with methylene blue. 
Intensity of 32p-cDNA/mRNA  hybridization signals  was quantified  by 
scanning films of exposed blots with an LKB 2202 Ultroscan Laser Den- 
sitometer (LKB-Proddukter  AB, Bromma, Sweden).  Intensities of bands 
from different blots were standardized to each other by assigning the most 
intense band on each gel an arbitrary value of 10, except for the/5-casein 
blot, which was assigned an arbitrary value of 30. This was done to show 
the  relationship of the  various  proteins  during  the  critical  interval  of 
proteinase-inhibitor changes  that take place concurrent with the drop in 
/3-casein expression.  The standardized intensity values were plotted against 
days of involution. 
Immunocytochemistry 
Immunofluorescence  staining for type IV collagen, laminin A-chain,  and 
casein was performed on frozen sections.  Mammary tissues were fixed in 
2% paraformaldehyde,  infused with 18 and 30% sucrose before embedding 
in Tissue-Tek OCT compound (Miles Sc. Div., Elkhart, IN), and frozen in 
an ethanol/dry ice bath. Sections  (5 #m) were cut with a Leitz cryotome 
onto gelatin-coated  slides and stained by immunottuorescence (Harlow and 
Lane,  1988). Briefly, nonspecific binding sites were blocked with wash so- 
lution. All washes were done for at least I h at ambient temperature or over- 
night at 4~  in  PBS  (130  mM  NaC1,  7  mM  Na2HPO4.7H20,  3  mM 
NaH2PO4.H20)  containing 0.1% BSA, 0.2%  Triton X-100, 0.05% Tween 
20, and 0.05% NAN3. Sections were incubated for 1 h, at ambient tempera- 
ture with either polyclonal rabbit antiserum to mouse laminin A-chain (gift 
of E. Engvall,  La Jolla Cancer Res. Inst., La Jolla, CA) at 1:I00 dilution, 
or polyclonal  rabbit antiserum to mouse type IV collagen (E.Y. Labs, 
San Mateo,  CA) at 1:300 dilution, or with FITC-conjugated  (Sambrook et 
al., 1989) mouse mAb to rat E-casein (gift ofC. Kaetzel, Case Western Re- 
serve Univelsity,  Cleveland, OH).  In the case of type IV collagen  and 
laminin A-chain, biotinylated anti-rabbit IgG (Amersham Corp.) followed 
by Texas red streptavidin were used at 1:50 dilution and 1:2,000 dilution, 
respectively, for 30 rain each at ambient temperature. In all sections, nuclei 
were  counterstained with 0.5  #g/ml DAPI  (4,6-diamino-2-phenylindole) 
(Sigma Chemical Co., St. Louis, MO) for 5 rain before the last wash. Zeiss 
epifluorescence  optics (Oberkochen, Germany) were used,  and photogra- 
phy was with TX-400 film (Eastman Kodak Co.). 
For SL staining, paraffin-embedded  sections were deparaffinized and re- 
hydrated.  Nonspecific protein binding sites were blocked by incubation of 
sections with ovalbumin (1 mg/ml) in PBS for 30 rain, followed by incuba- 
tion with a 20% solution of milk in PBS for 30 rain. Sections were further 
blocked with 5 % rabbit antiserum in PBS. Monoclonal mouse anti-human 
SL antibody (clone 2, 5 #g/ml in blocking buffer, gift of S. M. Wilhehm, 
Miles Research Center, West Haven, CT) was added to the sections and in- 
cubated for 1 h at ambient temperature and rinsed several times with PBS. 
Sections were then incubated in 5 % PBS for 30 rain, rinsed with PBS, and 
incubated with biotinylated secondary anti-mouse antibody (1:100) (Sigma 
Chemical Co.) for 30 rain at ambient temperature.  After washing as before, 
alkaline phospnatase-conjngated streptavidin (1:100) was added for another 
30 rain. Localization  of SL was detected by alkaline phosphatase substrate 
(ABC kit; Vector Laboratories Inc., Burlingame, CA). Endogenous  alka- 
line phosphatase activity was blocked by levamisole (Sigma Chemical Co.). 
Protein Blotting 
Mammary gland tissue extracts prepared as described previously  (Talhouk 
et al., 1991b), were resolved on 12% polyacrylamide  gels under denaturing 
conditions.  After electrophoresis,  resolved proteins were transferred to 
Immobilin-P membranes (MiUipore Continental Water Systems, Bedford, 
MA) using a dry blot apparatus (American Bionetics, Hayward, CA). Mem- 
branes were blocked overnight in a wash buffer (100 mM Tris-HC1 buffer, 
pH 7.5, 150 mM NaC1, 0.3 % Tween 20) with 2 % fatty acid free BSA (Sigma 
Chemical Co.).  The membranes were then incubated for 1 b in polyclonal 
rabbit anti-mouse milk antiserum (diluted  1:1,000 in blocking buffer) and 
washed 3 times, for 20 rain each time, to remove unbound antiserum. Bound 
antibody  was  detected  by  addition  of alkaline phosphatase-conjngated 
anti-rabbit IgG (Caltag Laboratories, South San Francisco,  CA), followed 
by BCIP/NBT (bromo-chloro-indolyl  phosphate/nitroblue  tetrazolium) (Sig- 
ma Chemical Co.). All washings and incubations were done at ambient  tem- 
perature. Biotinylated size markers were detected with alkaline  phosphatase- 
conjugated  streptavidin  (Zymed Laboratories Inc., San Francisco, CA). 
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sion  of  milk  proteins  and 
ECM-degrading  proteinases 
during involution. RNA blots 
of (A) B-casein and (C and D) 
ECM-degrading  proteinases 
are  shown.  Expression  of 
E-casein  mRNA  was  main- 
tained at high levels up to 4 d 
after involution and declined 
rapidly  after  that.  A  zymo- 
gram (B) shows that as early 
as  1  d  after  involution,  the 
72-kD  gelatinase  increased 
markedly  over that observed 
in lactating  mammary  tissue 
(L9).  The active form of 72- 
kD gelatinase (62 kD) began 
to appear on day three of in- 
volution, and remained prom- 
inent from days 4-10.  mRNA 
expression of ECM-degrading 
proteinases  SL  (C)  and  tPA 
(D) was noted only after day 
three of involution. 
SDS-Substrate Gels 
Zymograms and tissue extracts were prepared as described previously (Tal- 
houk et al.,  1991b). Zymogram gels consisted of 7% polyacrylamide  im- 
pregnated with gelatin at  1 mg/ml.  After electrophoresis the gels  were 
washed twice,  for 30 rain each time in 2.5% Triton X-100 solution at am- 
bient temperature, then incubated for 24 h in substrate buffer (50 mM Tris- 
HCI buffer, pH 8.0, 5 mM CaCI2,  0.02%  NAN3) at 37~  The gels were 
then stained in Coomassie blue R250 for 1 h and destalned in water over- 
night. Gelatin-degrading  enzymes were visualized as clear bands, indicat- 
ing proteolysis  of the substrate protein. Metalloproteinases are secreted  in 
a latent form and require cleavage ofa peptide from their NH2 terminus for 
activation.  However, exposure of proenzymes of the tissue extracts to SDS 
during gel  separation procedures leads  to activation without proteolytic 
cleavage (Talhouk et al., 1991b). Zymograms are shown as negative images 
for clarity. 
For preparation of samples,  freshly isolated  mammary tissue was im- 
mediately frozen in liquid nitrogen. The tissue was then pulverized to a fine 
powder, weighed,  and either stored at -70~  or suspended 1:5 (wt/vol) in 
extraction  buffer (1% Triton X-t00 in 500 mM Tris-HCl buffer, pH 7.6, con- 
taining 200 raM NaCI and 10 mM CaC12). The suspension was frozen on 
dry ice, thawed four times,  and microfuged  (12,000 g for 30 rain at 4~ 
The supernatant was removed and stored at -70~  until needed for zymog- 
raphy. Analysis of proteinase activity was based on equal amounts of protein 
(15/zg) in tissue extracts. 
Sealing of  Primary Duct of  Mammary Gland 
The mammary glands from two groups of mice were sealed by cauterization 
of the teat opening and of the surgically exposed primary duct after 2 d of 
lactation.  The first group consisted of normal lactating  mice; the second 
group had their pups removed immediately after cauterization,  leading to 
involution.  Mammary tissues from lactating, sealed,  and involuting glands 
were collected at 6 and 7 d after cauterization and processed for immunocy- 
tochemistry or RNA blot analysis  as described above.  Mammary tissues 
from two mice from each group were sampled for each stage of involution. 
Preparation of Slow-release Pellets 
Ethylene/vinyl acetate copolymer (EVAc; Du Pont Co., Boston, MA) slow- 
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of SL in involuting mammary 
gland.  Transverse  sections 
of  paratfin-embedded  tissue 
from (A, C, and E) a 9-d lac- 
tating  mammary  gland,  and 
(B, D, and F) 4-d involuting 
mammary  gland  after  a  9-d 
lactation  were  stained  with 
antibody to SL (A-D) or con- 
trol (E and F) are shown. A 
and B are phase-contrast mi- 
crographs  and  C and  D  are 
bright  field  rnicrographs,  of 
the same sections as in A and 
B, respectively, of mammary 
tissue incubated with SL anti- 
body. SL was observed around 
regressed alveoli (solid white 
arrow heads point to a group 
of regressed alveoli) of an in- 
voluting gland, but not around 
alveoli  (solid  black  arrow 
heads point to two alveoli) of 
a lactating gland. E and F are 
bright  field micrographs  of 
control transverse sections in- 
cubated without the SL anti- 
body (open black arrow heads 
point to alveoli in a lactating 
gland, and open white arrow 
heads point to a group of re- 
gressed alveoli). Note the dark 
staining observed around the 
alveoli in D but not in E Bar, 
50/~m. 
release implants were prepared according to Silberstein and Daniel (1987). 
A lyophilized mixture of  BSA (25 mg) and various concentrations of recom- 
binant human  TIMP  (expressed in Escherichia  coli,  a  gift of D.  Car- 
michael, Synergen Corp.,  Boulder, CO)  was dispersed with 0.125  mi of 
EVAc dissolved in dichloromethane (Sigma Chemical Co.). This mixture 
was immediately frozen, dried, and cut into 1-2-mg pieces. The pellets were 
then surgically implanted into the inguinal mammary gland (one mouse for 
each TIMP'concentration, and two implants per gland) after 2 d of involu- 
tion which was initiated by cessation of suckling after 2 d  of parturition. 
Mammary glands with implants and the contralateral inguinal gland in the 
same mouse were sampled at 1, 2, and 3 d after implantation (equivalent 
to 3, 4, and 5 d of  involution, respectively). Each gland was cut in two, fixed 
in 2 % paraformaldehyde, and then either embedded in paraffin for hematox- 
ylin and eosin staining or frozen in OCT compound as described earlier for 
immunofluorescence. 
Results 
ECM-Degrading Proteinases and Their Inhibitors Are 
Temporally Expressed during Involution 
We  determined  the  expression  of  ECM-degrading  pro- 
teinases  during  transition  of the  mammary  gland  from a 
differentiated lactational phenotype to a nonlactating pheno- 
type during involution. As involution of the gland was initi- 
ated after 9  d  of lactation,  three general events occurred. 
First, expression of/S-casein mRNA, a marker of lactational 
phenotype, dropped to one third immediately after involu- 
tion, remained there for 4 d after cessation of suckling, and 
then declined dramatically (Fig. 1 A). Second, expression of 
a number of ECM-degrading proteinases rose dramatically: 
the most prominent ECM-degrading proteinase detected in 
involuting tissue by substrate gel zymography was the 72-kD 
gelatinase (Fig.  1 B), as shown previously (Talhouk et al., 
1991b).  The 72-kD gelatinase, while low during lactation, 
was abundant as early as 1 d into involution and remained 
high throughout.  The active form of the 72-kD gelatinase 
(the 62-kD band) began to be detected on day three of involu- 
tion. SL, known for its wide range of ECM substrates (Tal- 
houk et al.,  1992;  Alexander and Werb,  1991),  and tPA, 
which is implicated indirectly in degradation of several ECM 
components (Alexander and Werb, 1991) were not expressed 
during lactation or the first 3 d of involution (Fig.  1, C and 
D). After 4 d of involution, and at least up to day 10 both 
SL mRNA and tPA mRNA were expressed at high levels. We 
have previously shown that the 72-kD gelatinase is secreted 
in the direction of the basement membrane (Talhouk et al., 
1991b).  Using a  monoclonal anti-SL antibody that recog- 
nizes  mouse  SL  in  protein  blots  (not  shown)  and  im- 
munolocalization analysis (Fig. 2), we observed SL in 4-d 
involuting, but not lactating,  tissue.  Secreted SL localized 
proximally to the basement membrane underlying the mam- 
mary epithelial ceUs in alveoli (Fig. 2) and around ducts (not 
shown), but not around fat cells, which are surrounded by 
their own basement membrane.  The third event that took 
place early in involution was  the  expression of TIME  an 
inhibitor of SL, 72-kD gelatinase, and other metalloprotein- 
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and PAI-1 mRNA expression 
during involution. Total RNA 
prepared  from lactating  and 
involuting  mammary  tissue 
was  analyzed by RNA blot- 
ting  for  expression  of  (A) 
TIMP and (B) PAId  (arrow 
head).  Note  that  expression 
of  these  inhibitors  peaked 
when  72-kD  gelatinase,  SL 
and tPA were first expressed 
during  involution  (see  Fig. 
1, B-D). Expression of inhib- 
itors  declined  with  that  of 
B-casein  mRNA  (see  Fig. 
1  A).  The  first  three  lanes 
of the  RNA  blot  for  PAI-1 
mRNA  (B) are  obscured by 
nonspecific background. This 
particular RNA blot was used 
because  the  RNA  samples 
shown are from the same ex- 
periment  as those  in Fig.  1, 
A-D and those in Fig. 3 A. In another experiment with RNA samples isolated from comparable stages of mammary development as those 
that are obscured above, we did not detect PAI-I mRNA expression (not shown). 
ases, and PAl-l, an inhibitor of plasminogen activators. Peak 
levels were reached at days 4-6, and subsequently declined 
(Fig. 3). On the basis of these data, we hypothesize that these 
events in involution are linked and that a high ratio of inhib- 
itors to ECM-degrading proteinases prevents degradation of 
the basement membrane for up to 4-5 d, maintaining accu- 
rate celI-ECM interactions and thus preserving functional 
epithelia that express B-casein. A diagram summarizing the 
change in expression of these gene products with time of in- 
volution is shown in Fig. 4. The loss of B-casein expression 
correlated closely with the onset of SL expression and the 
decline of TIMP expression more than it did with the onset 
of tPA expression and decline of PAId expression. Thus sub- 
sequent studies focused on the interrelation of metallopro- 
teinase levels and their inhibitor, TIMP. 
Modification of  Involution Is Correlated with Altered 
Expression of  ECM-degrading Proteinases and TIMP 
To test the first part of the above hypothesis, i.e., that the pat- 
tern of expression of ECM-degrading proteinases and inhibi- 
tots and the loss of mammary gland function are linked, it 
was necessary to modify involution and determine if tem- 
poral expression of these three events would change. We de- 
creased the interval of lactation to 2  d, resulting in a more 
rapid involution than that observed after 9  d  of lactation. 
While milk proteins were readily detectable by immunoblot 
analysis in gland extracts obtained after 9 d of lactation and 
persisted up to 2-3 d  into involution (Fig. 5 A), when the 
lactation period was reduced to 2 d they had diminished dra- 
matically by 2 d into involution (Fig. 5 B). After 9 d of lacta- 
tion, the expression of/3-casein mRNA was still abundant on 
day four of involution (Fig. 1 A), whereas after 2 d of lacta- 
tion, ~-casein mRNA disappeared by day four of involution 
(Fig. 6 A). After 2 d of lactation, expression of SL mRNA 
(Fig. 6 B) and tPA mRNA (Fig. 6 C) was low at day two but 
became high by day four and remained high at day seven of 
involution. Expression of TIMP mRNA (Fig. 6 D) peaked 
at 2 d of involution but had markedly decreased by day four. 
This temporal shift of critical events from 4-6 d after a 9-d 
lactation to 2-4 d after a 2-d lactation confirms the hypothe- 
sis that the three events discussed are interrelated. 
Presence of Lactogenic Hormones Modifies 
Metalloproteinases and Their Inhibitors 
To further examine the interrelation of metaUoproteinase ex- 
pression and loss of casein gene expression, we next took ad- 
vantage of reports that involution can be retarded in a non- 
suckled, hormonally stimulated gland (Schmidt, 1971). We 
asked  if this  retardation of involution could be  due to  a 
change  in  the  ratio of inhibitors  to  ECM-degrading  pro- 
teinases. To ensure that suckling did not occur, the primary 
duct of one of the mammary glands was sealed by cauteriza- 
tion. The sealed gland maintains its ability to make milk for 
prolonged periods if suckling of other nonsealed glands con- 
tinues owing to continued lactational stimulus. 6 d after cau- 
terization, the sealed gland expressed high levels of TIMP 
mRNA and low levels of SL mRNA, whereas its normal lac- 
tating counterpart in the same animal expressed neither (Fig. 
7 A). ~Casein expression was maintained for at least 7 d af- 
ter cauterization, with levels comparable with those of the 
lactating counterpart. On the other hand, in involuting tissue 
from completely weaned mice, ~-casein had declined sub- 
stantially by days 6-7  as  shown above,  and,  as  expected, 
these involuting glands expressed low levels of TIMP and 
high levels of SL. Therefore, ~-Casein expression was main- 
tained only when the ratio of SL to TIMP was low (Fig. 7 
B). Immunohistochemical analysis (Fig. 7  C) in lactating, 
sealed, and involuting mammary glands showed that casein 
and  alveolar structures  were  still  abundant  in  the  sealed 
gland comparable with those in lactating tissue.  Alveolar 
structures in involuting gland were regressed, and casein was 
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Figure 4. Summary of expression  of ECM-degrading proteinases, 
inhibitors,  and casein genes during involution after 9 d of  lactation. 
RNA blots were quantified  by densitometry and normalized to ar- 
bitrary units relative to the highest hybridization signal of mRNA/ 
eDNA for each transcript, as described in the text. Average values 
from duplicate  readings  were  plotted  against  days  of involution. 
Data plotted show the temporal regulation  of B-casein mRNA ex- 
pression  in relation  to that of (A) SL and TIMP, and (B) tPA and 
PAId. Critical events after a 9-d lactation occurred at 4-6 d of invo- 
lution. 
hardly evident  in the  remaining  alveoli.  Involuting glands 
sealed before weaning were indistinguishable  from normal 
involuting glands (data not shown). These results show that 
expression of "lIMP and,  to a lesser extent,  SL, is induced 
by local rather than systemic factors. Furthermore, they sug- 
Figure 5. Effect of lactation interval on accumulation of milk pro- 
teins  in the mammary gland during involution.  Immunoblots of 
mammary tissue  extracts  from (A) a 9-d lactating gland (Lg) and 
subsequent days of  involution and (B) a 2-d lactating gland (/_2) and 
subsequent  days of involution are shown. Tissue extracts were sub- 
jected to electrophoresis  on 12% SDS-polyacrylamide gels, trans- 
ferred onto a membrane, and analyzed with a broad-spectrum milk 
antibody  for  milk  proteins,  lactoferrin  (LF),  transferrin  (TF), 
casein (cas),  whey acidic protein (WAP), and tx-laetalbumin  (ot- 
lac). Both TF and LF are found in milk and in circulating blood. 
gest that the differentiated  status of the mammary gland is 
dependent  on  a  coordinated  and  critical  balance  between 
ECM-degrading proteinases and inhibitors: the lower the ra- 
tio of ECM-degrading proteinases to TIMP in an involuting 
gland,  the slower the process of involution. 
Figure 6. Effect of  lactation in- 
terval on expression of  B-casein 
and the ECM-degrading pro- 
teinase-inhibitor balance dur- 
ing involution.  RNA blots for 
(A) B-casein, (B) SL, (C) tPA, 
and (D) TIMP in tissue  from 
lactating and involuting mam- 
mary  glands  after  a  short 
(2 d) lactation (/_2) interval are 
shown. 
The Journal of Cell Biology, Volume 118, 1992  1276 Figure 7. Maintenance of lactogenic stimuli delays the onset of ex- 
pression of SL and prolongs the expression of TIMP and/~-casein. 
(.4) Total RNA from normal lactating gland, hormonally sufficient 
but nonsuckled sealed gland, and normal involuting gland was ana- 
lyzed by northern blot analysis for expression of SL, TIMP, and 
/~-casein. (B) Ratio of SL to TIMP obtained by densitometer scan- 
ning of SL and TIMP profiles shown in A. (C) Photomicrographs 
of casein localized by immunofluorescence in frozen sections from 
lactating, sealed, and involuting mammary glands. Bar, 50 ttm. 
The Raffo of TIMP to ECM-degrading Proteinases 
Regulates Involution 
The experiments described so far showed a strong correla- 
tion  between  an  increased  ratio  of ECM-degrading  pro- 
teinases to inhibitors and the loss of lactational differentia- 
tion. However, maintenance of the functional status of the 
sealed gland, although accompanied by a  shift in the ratio 
of SL to TIME could have been a result of maintenance of 
lactational stimulus and independent of ECM  remodeling 
events. To test directly the role of ECM remodeling in loss 
of  tissue-specific  function,  we  artificially  disrupted  the 
proteinase-inhibitor ratio during normal involution, a milieu 
devoid of lactational stimuli. If the loss of function of roam- 
Talhouk et al. Matrix-degrading Proteinases and Epithelial Function  1277 Figure 8. Exogenous TIMP inhibits involution  of  the mammary gland. (A) Transverse section of a typical  day four involuting mammary gland 
without an implant, stained with hematoxylin and eosin, with a predominant fat stroma and regressed alveolar  structures. Slow-release  EVAc 
pellets surgically implanted in a 2-d involuting mammary gland (after 2 d of lactation) with (B) no TIME (C) 0.1, (D) 1, (E) 5, and (F) 
10 #g TIMP show a concentration-dependent  effect evident  by a delay in the regression  of  the alveoli  2 d after implantation  of  the pellet  (equiva- 
lent to 4 d of involution). Note the large size of lumina and evidence of secretory activity in mammary glands receiving 5 or 10/zg of TIMP 
(E and F). Insets show the same tissue sections at lower magnification. The asterisk indicates the location of the EVAc pellet. Bars: (A-E) 
50 #m; (insets) 500 gin. 
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in the ratio of TIMP to SL, then the introduction of exoge- 
nous TIMP at the regulatory point should minimize ECM 
remodeling and alter the course of involution. To accomplish 
this,  we  prepared  slow-release  pellets  (Silberstein  and 
Daniel,  1982;  and Coleman and Daniel,  1990)  containing 
recombinant  human  TIMP,  which  has  previously  been 
shown to inhibit mammary metalloproteinases in zymogram 
assays (Talhouk et al., 1991b). In mammary glands weaned 
for 2 d after a 2-d lactation exposure to exogenous TIMP 
released from the implants delayed the onset of involution 
and prolonged the differentiated status of the gland. By day 
four of weaning,  mammary glands containing TIMP im- 
plants showed a concentration-dependent delay of involution 
(Fig. 8). The alveoli in involuting mammary glands contain- 
ing  TIMP  implants  maintained a  secretory  morphology 
resembling that of lactating alveoli. The majority of alveoli 
were well rounded, rather than convoluted, and many still 
surrounded a lumen that contained secretory products and 
fat-like droplets. In contrast, alveoli in the involuting glands 
in the same animal that did not contain implants, or that con- 
tained implants with no TIMP or only low concentrations of 
TIME were smaller, convoluted, and had small lumina evi- 
dent  in  only  a  few  of  the  alveoli.  This  concentration- 
dependent effect was noted in mice at days three and four of 
involution (1-2 d after implantation of the pellet). 3 d after 
implantation, no differences were noted between the glands 
that contained the TIMP implant and the glands that did not. 
This suggests that as the release of TIMP is lessened, the 
ECM-degrading proteinases and/or other soluble mammary 
effectors were able to override the inhibitory effect of exoge- 
nous TIME 
We  next  determined  whether  the  implants  containing 
TIMP could indeed retard the dissolution of the mammary 
alveolar basement membranes. In 4-d involuting gland, after 
a 2-d lactation, the basement membranes of both epithelial 
alveoli and fat cells stained with type IV collagen (Fig. 9 A), 
making it difficult  to distinguish whether the basement mem- 
brane surrounded the alveoli or fat cells. We exploited the 
observation that the basement membrane of fat cells does not 
contain the laminin A-chain isoform (Aratani and Kitagawa, 
1988) and used an antibody to laminin A-chain to examine 
the basement membrane of the mammary epithelial alveoli. 
In a 4-d involuting mammary gland with no implant, laminin 
A-chain antibody stained the small alveoli with an appar- 
ently continuous basement membrane (Fig. 9 B). Very little 
staining for casein was  observed in this gland.  The con- 
tralaterai gland with a  10/~g TIMP pellet implanted on day 
two of involution, on the other hand, showed much larger al- 
veoli with  continuous basement  membranes,  and greater 
numbers  of alveoli and lumina.  These  alveoli contained 
abundant casein (Fig. 9  C). Therefore, only alveoli in the 
gland with the TIMP implant, but not the contralateral one, 
maintained a lactational status. 
Discussion 
Few  reports  in  the  literature  describe  an  active  role  for 
ECM-degrading proteinases and their inhibitors in the regu- 
lation and maintenance of tissue-specific function (for re- 
view see Alexander and Werb, 1991; and Matrisian, 1990). 
The transition of the mammary gland from a differentiated 
lactational phenotype to a nonlactating phenotype during in- 
volution, and the concomitant dissolution of the basement 
membrane, is an ideal model for studying the effect of ECM 
on the function of secretory mammary epithelial cells in 
vivo. There is now compelling evidence that basement mem- 
brane instructs mouse mammary epithelial cells to acquire 
and maintain the tissue-specific lactational phenotype in cul- 
ture (Streuli et al., 1991; Streuli and Bissell, 1990; Chen and 
Bissell, 1989; Barcellos-Hoff  et al., 1989; Blum et ai., 1987; 
Li et al.,  1987).  An earlier study by Wicha et al.  (1980) 
demonstrated that inhibition of basement membrane deposi- 
tion in vivo in mammary glands of rats disrupted ductular 
branching and alveolar development. We have shown re- 
cently that loss of mammary gland function during involu- 
tion (Lascelles and Lee, 1978) correlates with an increase in 
expression of ECM-degrading proteinases (Talhouk et al., 
1991b). The present study was designed to test the hypothe- 
sis that proteolysis of basement membrane is responsible for 
loss of function of mammary gland during involution, and 
thus to provide direct critical evidence for the role of base- 
ment membrane in regulating functional differentiation in 
vivo. 
To dissect the mechanisms involved in loss of differen- 
tiated functions of mammary gland, we used three different 
ways to induce involution: (a) slow involution after 9 d of lac- 
tation; (b) rapid involution after 2 d of lactation; and (c) "in- 
volution" in a hormone-sufficient mammary gland in which 
the duct leading to one nipple was cauterized while other 
glands were still being suckled. Our data indicate that, while 
the patterns of regulation of ECM-degrading proteinases and 
inhibitors were distinct in each case, increased expression of 
ECM-degrading proteinases relative to inhibitors correlated 
with the onset of loss of tissue-specific function, measured 
by t-casein expression and morphology of the mammary 
gland. 
Loss of lactationai hormonal stimulus during involution 
(Forsyth, 1982) resulted in an immediate decrease in/~-casein 
expression on day one, but expression could be maintained 
at intermediate levels for up to 5 d of involution. The initial 
drop probably correlates with cessation of  suckling and secre- 
tion and hence feed back inhibition by intracellular accumu- 
lated milk (Wilde et  al.,  1990).  The  subsequent loss  of 
/~-casein expression in involution correlated with expression 
of  ECM-degrading proteinases that could alter celI-ECM in- 
teraction. Early in involution, when resumption of lactation 
and expression of milk proteins is still a possibility, the gland 
is engorged with milk for at least 2 d into involution (Hurley, 
1989),  as indicated by immunoblot analysis. At this point, 
ECM-degrading  proteinases  and  their  inhibitors  become 
critical players in regulating mammary gland function. Dur- 
ing the early stage of involution (days 1-4),  the gland could 
still maintain milk expression because the activity of ECM- 
degrading proteinases relative to their respective inhibitors 
was low. As the ratio of ECM-degrading proteinases to in- 
hibitors rose, there was an abrupt decrease in expression of 
milk proteins at 4 d. We believe this to be solely the function 
of  the proteinase to inhibitor ratio rather than additional hor- 
monai or other stimuli, because when we kept other param- 
eters constant but changed this ratio, we could modulate lac- 
tation. For example, a shorter interval of  lactation altered the 
kinetics of involution by precipitating an earlier decline in 
expression of milk proteins. 
In experiments where we prevented lactation in one set of 
Talhouk et al. Matrix-degrading Proteinases and Epithelial Function  1279 Figure 9. Immunohistochemical localization of (A) type IV collagen, (B) laminin A-chain, and (C)/3-casein in 4-d involuting glands with 
no EVAc  pellets (Control) and those with 10 ~g TIMP pellets 2 d after surgical implantation (4- TIMP). As in Fig. 8, the size and morphology 
of alveoli are markedly different in mammary gland receiving TIMP. Bar, 50/zm. 
mammary glands while other glands in the animal continued 
to be suckled, we could draw an additional conclusion: that 
expression of TIMP, in particular, and SL is independent of 
hormonal stimuli but related to loss of suckling, because the 
other glands in the same animal had no discernable enzyme 
expression. This observation perhaps explains why preven- 
tion of suckling delays involution but does not prevent it 
(Wellings and DeOme, 1963). The nonsuckled gland cannot 
maintain its functional status indefinitely in the presence of 
lysosomal enzymes (Hurley, 1987) and ECM-degrading pro- 
teinases. 
In experiments where we introduced exogenous TIMP to 
the involuting gland, thus reversing involution, we provided 
definitive evidence for the overriding effect of TIME  The 
higher the TIMP to metaUoproteinase ratio, the larger the al- 
veoli and the longer they could maintain a lactational pheno- 
type, as shown by accumulation of casein in the lumen. The 
detailed mechanism by which TIMP inhibits the action of 
ECM-degrading proteinases is not well understood.  How- 
ever, the inhibitors may bind to the basement membrane and 
inactivate  secreted  ECM-degrading  proteinases,  as  sug- 
gested by Saksela and Rifkin (1988) and Alexander and Werb 
(1991). 
The  literature on  the  fate of basement  membrane  sur- 
rounding the alveoli during involution is confusing. Earlier 
studies showed that the basement membrane is not lost dur- 
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it is in lactating tissue (Warburton et al., 1982; Richards and 
Benson, 1971; and Wellings and DeOme, 1963). Others have 
suggested that the basement membrane is hydrolysed during 
involution  (Martinez-Hernandez  et  al.,  1976).  However, 
these studies may have been misinterpreted owing to the 
difficulty in differentiating between basement membrane of 
fat cells and that of epithelial cells. In this study, we used an 
antibody to laminin A-chain that clearly distinguishes an in- 
tact basement membrane underlying mammary epithelial 
cells during involution. We saw a greatly diminished number 
of alveoli and, hence, less basement membrane in involu- 
tion. The remaining alveoli retained a stainable continuous 
basement membrane, which did appear to have thicker stain- 
ing, perhaps due to internal folding as some cell death oc- 
curs. Because exogenous TIMP released from implants not 
only prolonged the functional status of the alveoli, but also 
led to maintenance of larger alveoli with more secretory 
cells, we speculate that there is a role for the local effect of 
ECM-degrading proteinases in the absence of their respec- 
tive inhibitors. ECM-degrading proteinases secreted either 
by the epithelial cells  themselves (Talhouk et al.,  1991b; 
Monteagudo et al.,  1990)  or by fibroblasts (Basset et al., 
1990) would alter the interaction of certain cells within an 
alveolus with ECM and eventually lead to detachment of 
cells from the basement membrane and from neighboring 
cells in an alveolus. The basement membrane underlying the 
detaching cells is degraded,  Adjacent cells could be pro- 
tected from ECM-degrading proteinases by local concentra- 
tions of inhibitors such as PAI-1 or TIMP bound to their 
basement membrane (Alexander and Werb,  1991; Saksela 
and Rifkin, 1988).  The net result of this process would be 
smaller alveoli, as postulated by Wicha et al. (1980), as invo- 
lution proceeds. 
In the lactating gland, functional differentiation is main- 
tained with a minimal remodeling of ECM. A corollary and 
critical test of our hypothesis that basement membrane plays 
an active role in regulating differentiated function in vivo 
would  be  to  induce  expression  of ECM-degrading  pro- 
teinases during lactation. In studies to be reported separately 
(Talhouk, R.  S., C.  Sympson, C. M.  Alexander, S.  Clift, 
M. J. Bissell, and Z. Werb, manuscript in preparation), we 
generated transgenic mice that inappropriately express auto- 
activatable SL (Sanchez-Lopez et al., 1988) under the con- 
trol of the whey acidic protein promotor during lactation. 
In effect, a higher ratio of SL to inhibitor was artificially 
induced during lactation. A_lveoli in the mammary glands 
of these transgenic mice were  smaller than alveoli from 
nontransgenic, normal lactating mice and contained a dis- 
continuous basement membrane. This loss-of-function phe- 
notype is opposite to the gain-of-function phenotype in in- 
voluting mammary glands of mice with TIMP implants. 
Given our results in this and previous studies on mammary 
gland differentiation  (reviewed by Howler and Bissell, 1992; 
Talhouk et al., 1992),  we hypothesize that there are six dis- 
tinct steps by which a mammary epithelial cell maintains its 
differentiated status. (a) Induction of lactogenic hormones. 
(b) Formation of  a functional basement membrane in contact 
with manunary epithelial cells. What regulates formation of 
this basement membrane, and whether or not the composi- 
tion is different during different stages of development, is not 
known. (c) Expression of various integrins (and other ECM 
receptors)  to  modulate  interactions  of the  cell  with  its 
microenvironment. While a few mammary-specific  integrins 
have been identified, lack of rodent-specific antibodies has 
hampered a complete analysis of the integrins. (d) Interac- 
tion of the cell with its ECM. This interaction is possibly 
mediated via integrins. We have shown previously that a 
broad-spectrum/3~-integrin antibody disrupts/3-casein ex- 
pression in mammary cells in culture (Streuli et al., 1991). 
(e) Interaction ofintegrins with second and third messengers 
for intracellular signalling. (f) Expression of differentiated 
functions. We now know that milk protein genes, as exempli- 
fied by/3-casein, contain ECM response elements (Schmid- 
hauser et al.,  1990, 1992). 
In this study we have dealt only with the fourth step. Not 
only have we shown the importance of ECM to mammary 
function in  vivo, but we also have proven the corollary to the 
culture studies; i.e., if basement membrane is necessary for 
functional differentiation, then loss of basement membrane 
should lead to loss of function. 
In summary, we now have evidence that functional epithe- 
lial tissue in vivo maintains its differentiated status when 
minimal remodeling of ECM is occurring. CeI1-ECM inter- 
action can be altered in the presence of increased levels of 
ECM-degrading proteinases and/or in the absence of their 
inhibitors.  Because  inhibitors  play a  role  in  minimizing 
ECM remodeling, thus maintaining a  status quo of cell- 
ECM interaction, they are critical players in modulating cell 
morphology and function. What signals regulate the ECM- 
degrading proteinases and their inhibitors remains to be 
determined. 
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Note Added in Proof. While this manuscript was in press, a report that essen- 
tially confirms our time course of  proteinase expression after prolonged lac- 
tation was published. (Strange, R., ELi,  S. Saurer, A. Burkhardt, and 
R.  R.  Friis.  1992.  Apoptotic cell death and tissue remodelling during 
mouse mammary gland involution. Development  [Camb.].  115:49-58). 
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